June 10, 2014 - The Wall Street Journal, USA Today, Bloomberg, CBS, NBC and other media outlets covered today's announcement of a new collaboration between Autism Speaks and Google to accelerate advances in autism diagnosis, subtyping and treatment as part of Autism Speaks 10,000 Genomes Program.
New York, N.Y. (June 10, 2014) – Autism Speaks, the world’s leading autism science and advocacy organization, today announced a collaboration with Google to develop the world’s largest database of genomic sequence information on individuals with autism spectrum disorder (ASD) and their family members. The collaboration represents a significant milestone in advancing genomic research of the disorder, and could lead to breakthroughs into the causes, subtypes and better diagnosis and treatment for ASD.
The Rhode Island Consortium for Autism Research and Treatment (RI-CART) is creating the first statewide registry of children and adults with autism. The voluntary registry will support autism research and public advocacy by providing a rich source of anonymous information about families affected by autism, their health and quality of life, and their access to services.
NEW YORK, N.Y., (July 11, 2013) – A collaborative formed by Autism Speaks, the world’s leading autism science and advocacy organization, has found full genome sequencing examining the entire DNA code of individuals with autism spectrum disorder (ASD) and their family members to provide the definitive look at the wide ranging genetic variations associated with ASD.
New research adds to the evidence of a potential link between autism and sensitivities to gluten, a protein found in certain grains such as wheat. The researchers found that elevated antibodies to gluten were more common among children with autism than in others. In addition, the elevated antibody levels corresponded to GI symptoms such as pain and constipation.
New York, N.Y. (November 8, 2012) – Autism Speaks, the world’s leading autism science and advocacy organization, is proud to announce the release of biological and clinical data from 383 new families participating in Autism Speaks Autism Genetic Resource Exchange (AGRE) to researchers. AGRE is a resource for scientists that is comprised of clinical and biological data from families who have two or more children on the autism spectrum.
Clara Lajonchere, Ph.D., Autism Speaks vice president for clinical programs, will be a featured speaker at the biannual conference of the Autism Research Institute (ARI), October 13-14, in Anaheim, Calif.
NEW YORK, NY (May 10, 2012) – Autism Speaks today announced a partnership with its Autism Genetic Resource Exchange (AGRE) program and Prometheus Research to build a data management system that will support the integration and centralization of several of Autism Speaks leading data and biospecimen repositories. This expansion will provide the research community with access to extensive clinical data, tissue, and biospecimens from over 15,000 individuals with autism spectrum disorder (ASD) and their relatives from around the world.